PhD work improves superbug knowledge
In a previous life, Saki Baleivanualala was a microbiologist, working in a Fijian hospital where he saw many people dying from antibiotic resistant bacterial infections.
"I collected the clinical samples from the very patients that were admitted in the hospital in Fiji.
"Some of them didn't make it," he said.
"It is a growing global problem, and limited treatment options are already costing lives in the Pacific."
It was what inspired the 47-year-old to do a PhD at the University of Otago, investigating how antibiotic-resistant pathogens were spreading in Fijian hospitals.
What began as a study of the Fijian situation, quickly grew into a regional collaboration involving academic and health partners from Samoa, New Zealand and Australia as well.
By studying DNA and patterns of transmission, Mr Baleivanualala was able to map the movement of the superbug, which helped identify where, and how, the infections were spreading in hospitals.
His research showed it was being moved to different hospitals when patients were being transferred for different treatments.
"It was even caused by ward transfers within hospitals, and that points towards some gaps in terms of infection control practices that can be improved, based on the study.
"We managed to identify those gaps and that has helped the [Fijian] Ministry of Health to put guidelines in place to stop the spread."
This became a catalyst for setting up a permanent system to monitor antibiotic resistance in the other Pacific nations too.
"Setting something in place that means I can capacitate our locals — that is fulfilling," he said.
Mr Baleivanualala's research has earned him a PhD in microbiology and he will graduate today at a University of Otago graduation ceremony in the Dunedin Town Hall.
"I don't know what to say, but it's been a long journey, coming away from Fiji and at this age, to get the PhD.
"And not only getting the PhD, but seeing what I have been able to give back in terms of what I got from learning.
"I'm so very, very happy. It's been a rewarding process."
He is now working with partners to set up another genomic sequencing facility in Fiji, so local scientists can test samples in the country, rather than send them overseas for testing.
He is also continuing his research on antimicrobial resistance, while working at Fiji National University and the University of Otago microbiology department, mentoring young researchers and scientists.
john.lewis@odt.co.nz
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
2 days ago
- RNZ News
Prominent medical bodies call for release of delayed gender affirming healthcare guidelines
Te Whatu Ora was due to release the guidelines in March. Photo: RNZ / Angus Dreaver Prominent medical bodies are calling on the government to allow the release of updated gender affirming healthcare guidelines after a small section on puberty blockers caused it to be delayed. The guidelines were due to be released at the end of March but it's is now unclear when they will be. The Professional Association for Transgender Health Aotearoa, who was asked by Te Whatu Ora to update the guidelines, believes the delay is "due to unprecedented and inappropriate political interference". Te Whatu Ora says it'll publish the guidelines "once decisions are made by the government following the ministry's consultation process". Public submissions on the matter closed 20 January. But PATHA says the advice on puberty blockers in the guidelines was updated in November to reflect the Ministry of Health's new position and this was approved by Te Whatu Ora's National Clinical Governance Group. It says this advice makes up only six pages out of the total 182 pages of the document. The guidelines cover all aspects of gender-affirming care to support trans and non-binary people and their families to navigate healthcare. This includes whānau support, creating inclusive clinical environments, non-medical and non-surgical gender affirmation, speech and language therapy, fertility and sexual health, mental wellbeing, gender-affirming hormone therapy, and detransition, as well as specific guidance for Māori, Pasifika, and refugee and asylum seeker trans people, PATHA said. More than 300 medical bodies, community organisations, and individual healthcare professionals have signed an open letter calling for the government to allow Te Whatu Ora to release the guidelines. These include General Practice New Zealand (GPNZ), Royal New Zealand College of General Practitioners, The Paediatric Society of NZ, New Zealand College of Clinical Psychologists, New Zealand College of Primary Health Care Nurses, College of Child and Youth Nurses and New Zealand Nurses Organisation. PATHA president Jennifer Shields said delaying the release impacts on the ability to improve healthcare delivery and health outcomes for the transgender and non-binary population. "Less than 24 hours before the date of publication, there was an unnecessary, indefinite and unexplained delay in the publication of these clinical guidelines, we believe due to unprecedented and inappropriate political interference." In November, the government released its evidence brief on puberty blockers and a position statement which sets out its expectations for their use. It signalled its intention to consider regulating them in gender affirming care and tasked the ministry with consultation, opening up public submissions. Regulatory measures could include restricting prescribing puberty blockers in the context of gender affirming care for young people but not its use in other contexts, the ministry said. Further measures being considered by the ministry included updating clinical guidance and increasing monitoring of prescriptions. The Green Party has denounced the signalled change of approach. Medical practitioners are currently working with guidelines published in 2018. PATHA said Te Whatu Ora contacted it in 2023 to update these. "It is standard practice for guidelines to be periodically updated to ensure their content is kept up to date. PATHA submitted the updated guidelines in October 2024 and they followed the standard process for publication of a clinical guideline, and were approved by Te Whatu Ora's National Clinical Governance Group." Vice president Dr Rona Carroll said clinicians are asking for up-to-date guidance to provide appropriate and safe healthcare. "The need for this updated guidance is clear and something I hear from health professionals on a daily basis. We just want to be able to publish these guidelines so the clinicians who need them can use them." Health NZ Te Whatu Ora national clinical director primary and community care Dr Sarah Clarke said it acknowledges the guidelines currently being used are from 2018 and that the evidence base in this area continues to evolve. "In the interim, and ahead of the updated guidelines being published, our advice is that health professionals continue to provide effective care based on the best available evidence and consult and take advice from colleagues more experienced in this care when appropriate." Puberty blockers can be used as part of gender affirming care to delay the onset of puberty by suppressing oestrogen and testosterone. They are also used for precocious puberty in children, and the ministry says the same medications can be used in adults to treat endometriosis, breast and prostate cancer, and polycystic ovary syndrome. The evidence brief released in November and subsequent public consultation only looked at the use of blockers specifically as they related to gender affirming care. The ministry says overall, the evidence brief found "significant limitations in the quality of evidence for either the benefits or risks (or lack thereof) of the use of puberty blockers". Following the release of the evidence brief, the ministry directed clinicians to exercise caution in prescribing puberty blockers. At the time Shields said this was already in line with New Zealand best practice and it was reassuring to see the ministry recognise this.
RNZ News
2 days ago
- RNZ News
'HIV should not be a death sentence in Fiji' - call for testing amid outbreak
Photo: 123RF Fiji's Minister for Health & Medical Services has revealed the latest HIV numbers in the country to a development partner roundtable on the country's response. There were 490 new HIV cases from October - December last year, bringing the 2024 total to 1583. "Included in this number are 32 newborns diagnosed with HIV acquired through mother-to-child transmission," Dr Atonio Rabici Lalabalavu said. Fiji declared an outbreak of the disease in January. The Fiji Sun reported around 115 HIV-related deaths in the January-September 2024 period. Fiji's Central Division reported 1100 new cases in 2024, with 427 in the Western Division and 50 in the Northern Division. Of the newly recorded cases, less than half - 770 - have been successfully linked to care, of which 711 have been commenced on antiretroviral therapy (ART). Just over half were aged in their twenties, and 70 percent of cases were male. Dr Lalabalavu said the increase in HIV cases is also seeing an increase in tuberculosis and HIV co-infection, with 160 individuals in a year. He said the ministry strongly encourages individuals to get tested, know their status, and if it is positive, seek treatment. Atonio Lalabalavu Photo: Facebook / Ministry of Health & Medical Services And if it is negative, to maintain that negative status. "I will reiterate what I have said before to all Fijians - HIV should not be a death sentence in Fiji." In the Western Pacific, the estimated number of people living with HIV (PLHIV) reached 1.9 million in 2020, up from 1.4 million in 2010. At the time, the World Health Organisation said over the previous two decades, HIV prevalence in the Western Pacific had remained low at 0.1 percent. However, the low prevalence in the general population masked high levels of HIV infection among key populations.
Otago Daily Times
3 days ago
- Otago Daily Times
Vote to pursue $20m research into lakes
Find the money now or face "astronomically expensive restoration efforts" for Otago's deepwater lakes later, a regional councillor says. Cr Alexa Forbes, of Queenstown, said the Otago deep water lakes technical advisory group had clearly shown that research to support "proactive management" was far more cost-effective than remediation after degradation was evident. Voting in favour of the most ambitious research proposal in front of Otago regional councillors was a "no-brainer", Cr Forbes said yesterday. And councillors subsequently did vote unanimously in favour of pursuing an up to $20 million, 10-year monitoring and research effort for Lakes Wakatipu, Wānaka and Hāwea. Cr Forbes praised the decades-long campaigning by University of Otago freshwater scientist Associate Prof Marc Schallenberg and Guardians of Lake Wānaka president Don Robertson, who she said had both been raising the issue of the lakes' health "for a long, long time". Now, degradation of the lakes was "impossible to ignore", Cr Forbes said. "We've got multiple interconnected environmental stressors with long-term consequences for biodiversity, for our economics, for our water quality, for our environmental health and for how we live among these lakes," she said. "We can't move forward without evidence. "We can't not afford it. "The report makes the case for strategic research that can prevent astronomically expensive restoration efforts." The technical advisory group's report to the Otago Regional Council's science and resilience committee yesterday said recent test results had highlighted "concerning patterns and the limitations of the existing monitoring programme". Monitoring by the council showed algal biomass in the lakes had doubled in the past nine years. Invasive zooplanktonic and phytoplanktonic species had gained a foothold. And climate change signals had been observed in the region. However, it was "not clear exactly" why or how this was happening, because the monitoring programme now in place was not able to identify the "stressor-response relationships" at play, which limited its usefulness, the group's report said. Cr Elliot Weir said the $20m price tag for the work was "dwarfed by the economic and social and cultural and aesthetic benefits that those lakes bring". "Let's set this direction today," they said. "We do want to take care of these lakes and we'll invest quite heavily, if necessary, to fill those big knowledge gaps to do so." Council chairwoman Cr Gretchen Robertson said other organisations needed to get involved in the work. "We can't be the only organisation in this space. "And actually, we can't afford $20m. "But this is extremely important. "These lakes, as Cr Weir has just outlined, are incredibly valued, not just in Otago, but nationally. "They bring a huge amount to our country in terms of values Kiwis put on them — also international visitors. "We can't have them deteriorating. "Other lakes have got huge investment and research programmes that have been put into them once they've got to the point where they've deteriorated — we don't want to have that happening here." At the councillors' request the technical advisory group will now develop a more detailed research and monitoring plan at the $20m funding level. The group has also been asked to identify "funding opportunities" apart from the council to pay for the work.
